/주식/BDRX
BDRX

BDRX

USD

Biodexa Pharmaceuticals plc American Depositary Shs

$5.400+0.290 (5.675%)

실시간 가격

Healthcare
생명공학
영국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$5.110

고가

$5.860

저가

$5.110

거래량

0.03M

기업 기본 정보

시가총액

3.3M

산업

생명공학

국가

United Kingdom

거래 통계

평균 거래량

0.18M

거래소

NCM

통화

USD

52주 범위

저가 $5현재가 $5.400고가 $92

관련 뉴스

GlobeNewswire

Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion

November 3, 2025 Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion Biodexa

더 보기
Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion